Factory planning for water bottling projects
Decision guide | product validation
Establish shelf life with representative production lots in the actual bottle, closure, label and secondary pack, stored under justified normal and reasonably adverse distribution conditions. The protocol should define test intervals and microbiological, chemical, sensory and packaging endpoints before results are available. Shelf life is a product-specific conclusion, not a standard period copied from another brand. Qualified quality personnel must approve the study, applicable label rules and release criteria; accelerated work may support but should not silently replace real-time evidence.
01
Establish shelf life with representative production lots in the actual bottle, closure, label and secondary pack, stored under justified normal and reasonably adverse distribution conditions. The protocol should define test intervals and microbiological, chemical, sensory and packaging endpoints before results are available. Begin with product and process definition: document product and process definition from current site evidence; name the owner, source and review date. Use representative production lots next. Test normal and credible adverse representative production lots conditions; state the exception and stop rule. Close the bottle and closure variants stage through bottle and closure variants evidence, specifically a bottle and closure variants interface map with closed gaps or named owners and due dates.
Document product and process definition from current site evidence; name the owner, source and review date. Product and process definition risk: weak product and process definition evidence leaves ownership and the decision basis unclear. Retain a dated product and process definition basis with source, owner, status and approval.
Test normal and credible adverse representative production lots conditions; state the exception and stop rule. Representative production lots risk: incompatible representative production lots can block startup or permit an unsafe release. Retain a representative production lots test showing conditions, raw result, exception and disposition.
Trace bottle and closure variants across physical and responsibility interfaces; close or assign every dependency. Bottle and closure variants risk: unmapped bottle and closure variants leaves an interface outside effective control. Retain a bottle and closure variants interface map with closed gaps or named owners and due dates.
02
At normal storage condition, control the approved normal storage condition basis and reopen it after a relevant process, material or site change. Set adverse storage condition beside normal storage condition; observe adverse storage condition at the decision point with a named method and verified instrument status. Sampling intervals decides the case. Untested sampling intervals can fail when routine conditions vary. The normal storage condition table entry pairs its action with the controlled normal storage condition revision and its requalification trigger; the risk for adverse storage condition is that poorly located adverse storage condition can hide deterioration until product is affected.
Control the approved normal storage condition basis and reopen it after a relevant process, material or site change. For Normal storage condition, compare the result against the controlled normal storage condition revision and its requalification trigger; reject the option if outdated normal storage condition separates the approved basis from the installed condition.
Observe adverse storage condition at the decision point with a named method and verified instrument status. For Adverse storage condition, compare the result against the adverse storage condition location rationale, method and instrument status; reject the option if poorly located adverse storage condition can hide deterioration until product is affected.
Challenge sampling intervals at startup and stable production, then reconcile any difference. For Sampling intervals, compare the result against startup and stable sampling intervals results with approved exceptions; reject the option if untested sampling intervals can fail when routine conditions vary.
| Bottled Water Shelf-Life Study factor | Product and process definition action | Representative production lots failure | Bottle and closure variants retained evidence |
|---|---|---|---|
| Product and process definition | Document product and process definition from current site evidence; name the owner, source and review date | weak product and process definition evidence leaves ownership and the decision basis unclear | a dated product and process definition basis with source, owner, status and approval |
| Representative production lots | Test normal and credible adverse representative production lots conditions; state the exception and stop rule | incompatible representative production lots can block startup or permit an unsafe release | a representative production lots test showing conditions, raw result, exception and disposition |
| Bottle and closure variants | Trace bottle and closure variants across physical and responsibility interfaces; close or assign every dependency | unmapped bottle and closure variants leaves an interface outside effective control | a bottle and closure variants interface map with closed gaps or named owners and due dates |
| Normal storage condition | Control the approved normal storage condition basis and reopen it after a relevant process, material or site change | outdated normal storage condition separates the approved basis from the installed condition | the controlled normal storage condition revision and its requalification trigger |
03
Control starts with microbiological endpoints, passes through chemical endpoints, then tests taste odor and appearance. A failure of microbiological endpoints matters because unclear microbiological endpoints ownership delays containment, investigation and restart. For chemical endpoints, retain a signed chemical endpoints comparison using common assumptions and stated exclusions. At taste odor and appearance, contain the taste odor and appearance event before unrepresentative taste odor and appearance can pass a convenient trial and fail in routine use.
Assign microbiological endpoints to a named role with an escalation path and dated closure. Microbiological endpoints risk: Unclear microbiological endpoints ownership delays containment, investigation and restart. Detection and containment use the microbiological endpoints owner, escalation route and closure entry.
Compare chemical endpoints options on the same assumptions and state every exclusion. Chemical endpoints risk: Non-comparable chemical endpoints options can make weaker evidence appear acceptable. Detection and containment use a signed chemical endpoints comparison using common assumptions and stated exclusions.
Verify taste odor and appearance with representative inputs, operators and credible operating variation. Taste odor and appearance risk: Unrepresentative taste odor and appearance can pass a convenient trial and fail in routine use. Detection and containment use the taste odor and appearance protocol, actual conditions, raw results and approval.
04
Shelf life is a product-specific conclusion, not a standard period copied from another brand. Qualified quality personnel must approve the study, applicable label rules and release criteria; accelerated work may support but should not silently replace real-time evidence. Authorize package integrity checks from the package integrity checks trend, investigation trigger and dated review decision. Revisit deviation handling whenever disconnected deviation handling can expose product, people or continuity. Keep final shelf-life conclusion open; the final shelf-life conclusion project must approve final shelf-life conclusion only when gaps are closed or retained as named, dated actions. Close final shelf-life conclusion with the accepted final shelf-life conclusion record with residual actions, owners and due dates.
Trend package integrity checks, define the investigation trigger and record the review decision. Acceptance relies on the package integrity checks trend, investigation trigger and dated review decision. Without package integrity checks trends, drift can outrun investigation. Reopen Package integrity checks when that condition occurs.
Connect loss of deviation handling to product hold, safe state and continuity response. Acceptance relies on a cause-and-effect test linking deviation handling loss to the intended response. Disconnected deviation handling can expose product, people or continuity. Reopen Deviation handling when that condition occurs.
Approve final shelf-life conclusion only when gaps are closed or retained as named, dated actions. Acceptance relies on the accepted final shelf-life conclusion record with residual actions, owners and due dates. Open final shelf-life conclusion gaps can be mistaken for final acceptance. Reopen Final shelf-life conclusion when that condition occurs.
R
These sources support the risk-control method on this page. They do not set project-specific legal limits, test frequencies, engineering values or approvals; verify the current edition and local applicability before a decision.
Canadian Food Inspection Agency
Codex Alimentarius
U.S. FDA
Buyer questions
Document product and process definition from current site evidence; name the owner, source and review date. Keep the point open until its evidence owner and review date are named.
The controlled normal storage condition revision and its requalification trigger. A file name alone does not prove the actual conditions, result or disposition.
Non-comparable chemical endpoints options can make weaker evidence appear acceptable. Contain affected product or people, trace the effects and authorize restart against the approved rule.
Assign it to a named role. Seek specialist, supplier or authority confirmation where the evidence crosses the project team’s competence boundary.
Move this project question forward
Control starts with microbiological endpoints, passes through chemical endpoints, then tests taste odor and appearance. A failure of microbiological endpoints matters because unclear microbiological endpoints ownership delays containment, investigation and restart. For chemical endpoints, retain a signed chemical endpoints comparison using common assumptions and stated exclusions. At taste odor and appearance, contain the taste odor and appearance event before unrepresentative taste odor and appearance can pass a convenient trial and fail in routine use.
Not sure which data matters? Send what you have and state the decision you need to make.
Send target capacity and SKUs, source-water report, site utility schedule, building layout and required project milestones.
The project desk can identify missing inputs and a practical next step. Final engineering, configuration, compliance and commercial terms remain project-specific.
Allot Tech (Suzhou) Co., Ltd. · sales@allottech.com · Project telephone: +86 186 6213 1120 / +1 818 262 0958